TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Abera Bioscience AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,646
|
0
|
1,190 |
Financial expenses |
0
![]() |
0
|
1 |
Earnings before taxes |
-16,717
|
-19,380
|
-9,165 |
EBITDA |
-16,799
|
-19,393
|
-9,164 |
Total assets |
9,350
|
19,574
|
31,374 |
Current assets |
7,438
|
17,686
|
12,436 |
Current liabilities |
3,692
|
2,795
|
2,221 |
Equity capital |
5,658
|
16,779
|
29,153 |
- share capital |
1,157
|
1,033
|
837 |
Employees (average) |
6
![]() |
6
|
5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
60.5%
|
85.7%
|
92.9% |
Turnover per employee |
441
|
0
|
238 |
Profit as a percentage of turnover | -631.8% | -770.2% | |
Return on assets (ROA) |
-178.8%
|
-99.0%
|
-29.2% |
Current ratio |
201.5%
|
632.8%
|
559.9% |
Return on equity (ROE) |
-295.5%
|
-115.5%
|
-31.4% |
Change turnover |
2,646
|
-1,190
|
1,190 |
Change turnover % | -100% | ||
Chg. No. of employees |
0
|
1
|
0 |
Chg. No. of employees % |
0%
|
20%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.